# PD-L1 Expression in Japanese Renal Cell Carcinoma Patients

> **NCT03748901** · — · COMPLETED · sponsor: **Chugai Pharmaceutical** · enrollment: 830 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03748901
- **Lead sponsor:** Chugai Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-16
- **Primary completion:** 2021-07-21
- **Final completion:** 2021-07-21
- **Target enrollment:** 830 (ACTUAL)
- **Last updated:** 2021-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03748901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03748901, "PD-L1 Expression in Japanese Renal Cell Carcinoma Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03748901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*